Business
Pine Labs IPO Price Band Announced: GMP Jumps To 27.14%, Check Key Dates
Last Updated:
Pine Labs sets IPO price at Rs 210-221 per share for Rs 3,900 crore issue, with listing on BSE and NSE on November 14, 2025.
Pine Labs Fixes Price Band
Pine Labs IPO Price Band, GMP, And Key Dates: The fintech firm Pine Labs has announced the price band of Rs 210-221 per share for its upcoming initial public offering (IPO) amounting to Rs 3,900 crore. The payment gateway platform is backed by Peak XV Partners, Mastercard, PayPal, and Temasek Holdings.
The IPO consists both fresh issue worth Rs 2,080 crore and offer-for-sale (OFS) of 8.23 crore equity shares. Previously, the issue had an offer-for-sale of 14.78 crore equity shares.
Peak XV Partners, Macritchie Investments, Madison India, Mastercard Inc, PayPal Inc, AIM Investment Funds, and Actis Pine Labs Investment Holdings are selling their shares via the issue.
At the upper price band, the valuation of Pine Labs has touched Rs 25,377 crore.
Axis Capital, Morgan Stanley, Citi, JPMorgan, and Jefferies are book running lead managers, while KFin Technologies Limited is the registrar.
Pine Labs Opening Window And Key Dates
Pine Labs IPO will open between November 07, 2025 and November 11, 2025. The allotment is likely to be concluded on November 12, 2025, with the listing of BSE and NSE scheduled for November 14, 2025.
Pine Labs Financials
Pine Labs turned profitable this quarter to report at Rs 47.86 million for Q1FY26 after a string of losses. However, the fintech received a tax credit of Rs 96.35 million because of losses.
FY25 still shows a loss of Rs 1,454.87 million, but it’s smaller than FY24’s Rs 3,419.03 million.
The company reported a total income of Rs 6,530.76 million. However, its total expenses stood at Rs 6,578.63 million for the June 2025 quarter.
Pine Labs IPO Objectives
The proceeds of the IPO will be utilized for investment in certain of its subsidiaries, namely Qwikcilver Singapore, Pine Payment Solutions, Malaysia and Pine Labs UAE for expanding presence outside India.
Moreover, a portion of proceeds will be used to build and strengthen IT assets, expenditure towards cloud infrastructure, technology development initiatives, and procurement of DCPs.
The company will also use proceeds to repayment/prepayment of certain borrowings availed by the company and its subsidiaries.
Pine Labs IPO GMP Today
According to market observers, unlisted shares of Pine Labs Ltd are currently trading at Rs 281 apiece in the grey market, against the upper IPO price of Rs 221. It means a grey market premium (GMP) of 27.14%, indicating decent listing gains for investors.
The GMP is based on market sentiments and keeps changing. ‘Grey market premium’ indicates investors’ readiness to pay more than the issue price.
Disclaimer: The views and investment tips by experts in this News18.com report are their own and not those of the website or its management. Users are advised to check with certified experts before taking any investment decisions.

Varun Yadav is a Sub Editor at News18 Business Digital. He writes articles on markets, personal finance, technology, and more. He completed his post-graduation diploma in English Journalism from the Indian Inst…Read More
Varun Yadav is a Sub Editor at News18 Business Digital. He writes articles on markets, personal finance, technology, and more. He completed his post-graduation diploma in English Journalism from the Indian Inst… Read More
November 03, 2025, 08:02 IST
Read More
Business
Hetero rolls out generic semaglutide exports to over 75 countries – The Times of India
Hyderabad: Pharma player Hetero on Friday said it has rolled out exports of its generic semaglutide injection portfolio as part of a multi-year plan to widen access to treatments for type 2 diabetes and obesity in more than 75 countries.The Hyderabad-based pharmaceutical company said initial rollouts are under way in Africa, Asia and the Middle East, with additional launches planned in other markets subject to regulatory approvals.The injectable therapies will be sold under the brand names Truglyx, Rolmodl and Moto G. Semaglutide belongs to the GLP-1 class of medicines, which are used in diabetes care and weight management.Hetero said the export launch is part of its broader strategy to improve access to advanced cardio-metabolic therapies, particularly in emerging markets.The company said the products will be offered in multi-dose disposable pen devices designed in line with innovator formats and will be available in several strengths, including 0.25 mg, 0.5 mg, 1 mg, 2 mg, 1.7 mg and 2.4 mg, allowing dosing flexibility for both diabetes and obesity treatment.Hetero said it is also awaiting approval from India’s Central Drugs Standard Control Organisation (CDSCO) after completing clinical trials in type 2 diabetes and obesity and plans an India launch after regulatory clearance.Hetero managing director Dr Vamsi Krishna Bandi said the company aims to provide high-quality, affordable generic semaglutide through a single global product platform backed by its manufacturing and development capabilities.He said Hetero would use its commercial networks across Asia, the Middle East, Africa and Latin America to support supply and access. The Hyderabad-headquartered Hetero operates in more than 145 countries and employs over 30,000 people.
Business
India-US trade deal update: Piyush Goyal meets USTR Jamieson Greer, discusses next steps in BTA talks – The Times of India
Commerce and industry minister Piyush Goyal on Friday met US Trade Representative Jamieson Greer and reviewed the next steps in negotiations for the proposed India-US bilateral trade agreement (BTA).The meeting took place on the sidelines of the 14th ministerial conference (MC14) of the World Trade Organisation in Yaounde, Cameroon, where both sides also exchanged views on issues related to the WTO agenda.“Had a very productive discussion with @USTradeRep Jamieson Greer on the sidelines of the WTO Ministerial Conference. Exchanged views on the #WTOMC14 agenda, next steps in the India-US BTA negotiations and explored ways to further deepen our economic cooperation and bilateral trade ties,” Goyal said in a social media post.The development comes amid ongoing efforts by both countries to finalise an interim trade pact. Last month, India and the US announced that they had finalised a framework for the first phase of the agreement, though it is yet to be signed.The two sides had earlier announced a trade deal on February 2, followed by a joint statement on February 7 outlining the contours of the agreement.As part of the framework, the US had agreed to reduce tariffs on Indian goods to 18%. However, the tariff structure has since undergone changes after the US Supreme Court struck down sweeping tariffs imposed under earlier measures.Following the ruling, US President Donald Trump introduced a 10% tariff on all countries for a period of 150 days starting February 24.In view of these developments, a planned meeting between chief negotiators of India and the US — aimed at finalising the legal text of the agreement — has been postponed. The pact was earlier expected to be signed this month.An official had earlier said that the interim trade agreement would be signed once the new global tariff framework of the US is fully in place.
Business
It has never been easier to start investing. As more take advantage, should you?
When you think of an investor, what kind of person comes to mind? What are their interests, their job? Are they an older man wearing a pin-striped suit and a bowler hat?
It might surprise you that the average investor age in the UK is 49 years old – down from 55 years old over the last five years.
And with more than 13 million DIY investor accounts in the UK, it’s likely that the average investor looks more like one of your mates than someone out of The Wolf of Wall Street.
The UK is historically quite wary of investing, and it’s been something that the financial industry and governments have been trying to tackle for years.
We’re starting to see the fruits of these efforts trickle through; latest Boring Money data reveals that DIY investing accounts grew over 19 per cent in the last year. Roughly one-third of the population now invests, up from about a quarter in 2020, and it’s becoming more mainstream by the day.
Start small, stay consistent – let the market do the work
It’s a common misconception that you need to have a lot of money to be an investor. The median amount invested by DIY investors is around £15,000, but you can start with as little as £1.
Neither does it have to be done in one big hit. Lots of providers allow you to set up regular investing – often £25 a month minimum, but a few let you regularly invest less.
Setting up these direct debits can also be a good idea – you drip feed into markets and average out the price which you buy at, so smoothing out any ups and downs along the way.
And you don’t have to be a maths genius or obsessively checking the markets – there are plenty of tools and account types that can do this for you.
Get a free fractional share worth up to £100.
Capital at risk.
Terms and conditions apply.
ADVERTISEMENT
Get a free fractional share worth up to £100.
Capital at risk.
Terms and conditions apply.
ADVERTISEMENT

Robo-advisors are automated, algorithm-driven financial planning and investment services requiring little to no human supervision. A typical robo-advisor asks questions about your financial situation and future goals when you set up the account, then will match you to one of their ready-made portfolios and automatically invest for you.
Find your investment “playlist”
If you don’t want to go down the robo-route, but aren’t sure which to pick, you can take a look at some of last year’s best-selling funds for inspiration. These four funds below appeared on multiple investment platforms’ best-selling lists every month in 2025.
They are all low-cost global collections of shares which are well diversified. Think of them like an investment playlist curated for you to serve up a bundle of shares in one easy-to-buy package.
The idea is that you can buy one product which is very broadly spread around lots of different companies which minimises the risk of any one thing going horribly wrong.

Fidelity Index World: a very cheap way to buy about 1,300 of the world’s largest companies in one go, pre-wrapped into one single investment product which costs about £1.20 a year for every £1,000 invested here.
HSBC FTSE All-World Index: a similar global option with over 3,000 companies and emerging markets too, so you get exposure to India, China and Brazil too, for example. Good if you don’t want too much exposure to the US.
Vanguard FTSE Global All Cap Index: a very diversified option. It has shares in about 7,000–8,000 companies with a small proportion in smaller companies, about 10 per cent in emerging markets, and slightly less in the US than some peers – a bit pricier than some trackers but still really good value – about £2.30 a year for every £1,000 invested here.
Vanguard LifeStrategy 100% Equity: one with a heavier British weighting – about 20 to 25 per cent invested in the UK.
Starting from scratch
If you’re a total beginner and want one of these global options to get started, you could compare platforms which will let you buy funds and won’t cost a lot for a small amount. Hargreaves Lansdown and AJ Bell are good options if you have small balances and want to buy a fund like the above. Or you can open an ISA with Vanguard and pop one of their ready-made ‘LifeStrategy’ funds into it.
If you prefer to buy and sell shares or exchange traded funds then Trading 212 and Freetrade are good low-cost ISA providers for smaller balances.
Investing has never been easier.
The average investor age is dropping, the amount you need to invest is low, and people are investing less, but more regularly. There are plenty of different platforms, things to invest in and ways to invest.
People talk about “time in the market, not timing the market” – that means if you’re in it for the long-haul, and can afford to invest small amounts regularly, you’ll be in a great place further down the line. The most important thing is to just get started and build up over time.
When investing, your capital is at risk and you may get back less than invested. Past performance doesn’t guarantee future results.
-
Entertainment1 week agoVal Kilmer revived 1 year after death through AI
-
Fashion6 days agoChina’s textile & apparel exports surge 17% to $50 bn in Jan-Feb 2026
-
Business1 week agoVideo: The Effects of High Oil Prices
-
Business7 days agoFlipkart group CFO to leave co amid IPO plans – The Times of India
-
Sports7 days agoRating Adidas’ 2026 World Cup away shirts: Argentina, Spain, Mexico and more
-
Sports7 days agoAmerican Conference Commissioner Tim Pernetti thanks Trump for Army-Navy game executive order
-
Tech1 week ago
The Corsair 4000D RS PC Case Keeps Your System Cool
-
Fashion1 week agoThe hidden $1.62 war tax now embedded in every garment you source
